GlobeStar Therapeutics Corporation
GlobeStar Therapeutics Corporation (GSTC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GSTC · as of Jun 9, 2026
Key Statistics
Explore GlobeStar Therapeutics Corporation Data
gstc stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
gstc competitorsGSTC
ACUS
AMPE
BIOAF
EHOS
GBLXStock Performance
Full HistoryAbout GlobeStar Therapeutics Corporation
GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing proprietary drug formulations. These innovative treatments specifically target multiple sclerosis (…
what is globestar therapeutics corporation · gstc stock overview · globestar therapeutics corporation company profile · who is globestar therapeutics corporation ceo · gstc OTC · globestar therapeutics corporation headquarters · globestar therapeutics corporation business segments
About Stock Overview & Key Data
GlobeStar Therapeutics Corporation (GSTC) is a Healthcare company in the Biotechnology industry, listed on OTC since Sep 26, 2011. As of the latest trading session, GSTC stock price is $0.00, with a market capitalization of $124,111. The stock has returned +0.00% over the past 12 months and +9900.00% year-to-date.
In fiscal year 2023, GlobeStar Therapeutics Corporation reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, GlobeStar Therapeutics Corporation (GSTC) stock price is $0.00. The stock is traded on OTC under the ticker symbol GSTC. The 52-week range is $0.00 – $0.00.